Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Presentation of an In Silico and In Vitro Exploration into Combining FDA-Approved Therapies for Treatment-Resistant Melanoma

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: CICALI, Brian (Stockton University, Galloway, United States)
  • Co-author(s): Brian Cicali: Natural Sciences and Mathematics, Stockton University, Galloway, United States
    Robert Olsen: Natural Sciences and Mathematics, Stockton University, Galloway, United States
  • Abstract:

    Backgrounds

    Melanoma is the deadliest form of skin cancer, killing over 10,000 people annually in the United States. Although multiple FDA-approved therapies exist, treatment resistance is a major issue for oncologists.

    Aims

    This project utilizes in silico and in vitro experimentation to explore combination treatments of established melanoma

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses